Detalhe da pesquisa
1.
A Bayesian model with application for adaptive platform trials having temporal changes.
Biometrics
; 79(2): 1446-1458, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35476298
2.
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.
N Engl J Med
; 378(21): 1976-1986, 2018 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29658848
3.
Individualized treatment effects with censored data via fully nonparametric Bayesian accelerated failure time models.
Biostatistics
; 21(1): 50-68, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30052809
4.
A batch-effect adjusted Simon's two-stage design for cancer vaccine clinical studies.
Biometrics
; 77(3): 1075-1088, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822525
5.
Leveraging real-world evidence for determining performance goals for medical device studies.
Stat Med
; 40(29): 6577-6589, 2021 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34561895
6.
Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods.
Clin Trials
; 18(1): 3-16, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33258698
7.
Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(11): 2075-2081, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818556
8.
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period.
Breast Cancer Res Treat
; 180(3): 695-706, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162192
9.
Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015.
Breast Cancer Res Treat
; 181(3): 623-633, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32378051
10.
Bayesian copy number detection and association in large-scale studies.
BMC Cancer
; 20(1): 856, 2020 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894098
11.
Discussion on "Predictively consistent prior effective sample sizes," by Beat Neuenschwander, Sebastian Weber, Heinz Schmidli, and Anthony O'Hagan.
Biometrics
; 76(2): 599-601, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251527
12.
The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations.
J Biopharm Stat
; 30(6): 1026-1037, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941098
13.
Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 25(6): 1128-1135, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30599208
14.
Dependent generalized Dirichlet process priors for the analysis of acute lymphoblastic leukemia.
Biostatistics
; 19(3): 342-358, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28968716
15.
A Bayesian nonparametric causal inference model for synthesizing randomized clinical trial and real-world evidence.
Stat Med
; 38(14): 2573-2588, 2019 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30883861
16.
A Bayesian design for phase I cancer therapeutic vaccine trials.
Stat Med
; 38(7): 1170-1189, 2019 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30368868
17.
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(2): 343-352, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29055682
18.
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1022-1028, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353109
19.
Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.
Biol Blood Marrow Transplant
; 24(5): 1099-1102, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29452245
20.
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer.
Cancer
; 124(9): 1904-1911, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29381193